Left atrial appendage exclusion for atrial fibrillation

Cardiology Clinics

Volumn 32, Issue 4, 2014, Pages 601-625

  Syed, Faisal F ^a   DeSimone, Christopher V ^a   Friedman, Paul A ^a   Asirvatham, Samuel J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Atrial fibrillation; Left atrial appendage; Percutaneous appendage closure; Stroke prevention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DABIGATRAN; TICLOPIDINE; WARFARIN;

AMPLATZER CARDIAC PLUG; AMPLATZER VASCULAR PLUG; ANTICOAGULANT THERAPY; ARTERIOVENOUS FISTULA; BLEEDING; CARDIOEMBOLIC STROKE; CARDIOVASCULAR DISEASE ASSESSMENT; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CHADS2 SCORE; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMBOLISM; FALSE ANEURYSM; FIBEROSCOPE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEMATOMA; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LEFT ATRIAL APPENDAGE; LEFT ATRIAL APPENDAGE CLOSURE; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MINIMALLY INVASIVE CARDIAC SURGERY; NONHUMAN; PERCUTANEOUS LEFT ATRIAL APPENDAGE TRANSCATHETER OCCLUSION SYSTEM; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; PERICARDIAL PAIN; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SURGICAL APPROACH; SUTURE DELIVERY DEVICE; THROMBOEMBOLISM; THROMBOGENICITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ARTIFICIAL EMBOLISM; ATRIAL FIBRILLATION; CLINICAL TRIAL (TOPIC); COMPLICATION; HEART CATHETERIZATION; LIGATION; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SEPTAL OCCLUDER; STROKE; SURGERY; TIME;

ATRIAL APPENDAGE; ATRIAL FIBRILLATION; CARDIAC CATHETERIZATION; CLINICAL TRIALS AS TOPIC; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HUMANS; LIGATION; OUTCOME ASSESSMENT (HEALTH CARE); RISK ADJUSTMENT; RISK FACTORS; SEPTAL OCCLUDER DEVICE; STROKE; THERAPEUTIC OCCLUSION; TIME FACTORS;

EID: 84927558948     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2014.07.006     Document Type: Review

References (178)

1. Blackshear J.L., Johnson W.D., Odell J.A., et al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. JAm Coll Cardiol 2003, 42(7):1249-1252.
2. Blackshear J.L., Odell J.A. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996, 61(2):755-759.
3. Hart R.G., Pearce L.A., Miller V.T., et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 2000, 10(1):39-43.
4. Naya T., Yukiiri K., Hosomi N., et al. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation. Cerebrovasc Dis 2008, 26(4):434-440.
5. Mahajan R., Brooks A.G., Sullivan T., et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart 2012, 98(15):1120-1126.
6. Chimowitz M.I., Lynn M.J., Howlett-Smith H., et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. NEngl J Med 2005, 352(13):1305-1316.
7. Syed F.F., Asirvatham S.J. Left atrial appendage as a target for reducing strokes: justifiable rationale? Safe and effective approaches?. Heart Rhythm 2011, 8(2):194-198.
8. Holmes D.R., Fountain R. Stroke prevention in atrial fibrillation: WATCHMAN versus warfarin. Expert Rev Cardiovasc Ther 2009, 7(7):727-729.
9. Klein A.L., Grimm R.A., Murray R.D., et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. NEngl J Med 2001, 344(19):1411-1420.
10. Friedman P.A., Holmes D.R. Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation. JCardiovasc Electrophysiol 2011, 22(10):1184-1191.
11. Yu C.M., Khattab A.A., Bertog S.C., et al. Mechanical antithrombotic intervention by LAA occlusion in atrial fibrillation. Nat Rev Cardiol 2013, 10(12):707-722.
12. Brass L.M., Krumholz H.M., Scinto J.M., et al. Warfarin use among patients with atrial fibrillation. Stroke 1997, 28(12):2382-2389.
13. Onalan O., Lashevsky I., Hamad A., et al. Nonpharmacologic stroke prevention in atrial fibrillation. Expert Rev Cardiovasc Ther 2005, 3(4):619-633.
14. James T.N. Small arteries of the heart. Circulation 1977, 56(1):2-14.
15. Al-Saady N.M., Obel O.A., Camm A.J. Left atrial appendage: structure, function, and role in thromboembolism. Heart 1999, 82(5):547-554.
16. Cabrera J.A., Saremi F., Sanchez-Quintana D. Left atrial appendage: anatomy and imaging landmarks pertinent to percutaneous transcatheter occlusion. Heart 2014, 10.1136/heartjnl-2013-304464.
17. De Simone C.V., Noheria A., Lachman N., et al. Myocardium of the superior vena cava, coronary sinus, vein of Marshall, and the pulmonary vein ostia: gross anatomic studies in 620 hearts. JCardiovasc Electrophysiol 2012, 23(12):1304-1309.
18. Macedo P.G., Kapa S., Mears J.A., et al. Correlative anatomy for the electrophysiologist: ablation for atrial fibrillation. Part I: pulmonary vein ostia, superior vena cava, vein of Marshall. JCardiovasc Electrophysiol 2010, 21(6):721-730.
19. Su P., McCarthy K.P., Ho S.Y. Occluding the left atrial appendage: anatomical considerations. Heart 2008, 94(9):1166-1170.
20. Lemery R., Guiraudon G., Veinot J.P. Anatomic description of Bachmann's bundle and its relation to the atrial septum. Am J Cardiol 2003, 91(12):1482-1485. A1488.
21. Friedman P.A., Asirvatham S.J., Dalegrave C., et al. Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach. JCardiovasc Electrophysiol 2009, 20(8):908-915.
22. De Ponti P., Ho S.Y., Salerno-Uriarte J.A., et al. Electroanatomic analysis of sinus impulse propagation in normal human atria. JCardiovasc Electrophysiol 2002, 13(1):1-10.
23. Markides V., Schilling R.J., Ho S.Y., et al. Characterization of left atrial activation in the intact human heart. Circulation 2003, 107(5):733-739.
24. Cosio F.G., Martin-Penato A., Pastor A., et al. Atrial activation mapping in sinus rhythm in the clinical electrophysiology laboratory: observations during Bachmann's bundle block. JCardiovasc Electrophysiol 2004, 15(5):524-531.
25. Lemery R., Birnie D., Tang A.S., et al. Normal atrial activation and voltage during sinus rhythm in the human heart: an endocardial and epicardial mapping study in patients with a history of atrial fibrillation. JCardiovasc Electrophysiol 2007, 18(4):402-408.
26. Matsumoto Y., Krishnan S., Fowler S.J., et al. Detection of phrenic nerves and their relation to cardiac anatomy using 64-slice multidetector computed tomography. Am J Cardiol 2007, 100(1):133-137.
27. Lachman N., Syed F.F., Habib A., et al. Correlative anatomy for the electrophysiologist, part II: cardiac ganglia, phrenic nerve, coronary venous system. JCardiovasc Electrophysiol 2011, 22(1):104-110.
28. Wongcharoen W., Tsao H.M., Wu M.H., et al. Morphologic characteristics of the left atrial appendage, roof, and septum: implications for the ablation of atrial fibrillation. JCardiovasc Electrophysiol 2006, 17(9):951-956.
29. Ernst G., Stollberger C., Abzieher F., et al. Morphology of the left atrial appendage. Anat Rec 1995, 242(4):553-561.
30. Veinot J.P., Harrity P.J., Gentile F., et al. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation 1997, 96(9):3112-3115.
31. Ramaswamy P., Lytrivi I.D., Srivastava S., et al. Left atrial appendage: variations in morphology and position causing pitfalls in pediatric echocardiographic diagnosis. JAm Soc Echocardiogr 2007, 20(8):1011-1016.
32. Beinart R., Heist E.K., Newell J.B., et al. Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. JCardiovasc Electrophysiol 2011, 22(1):10-15.
33. Wang Y., Di Biase L., Horton R.P., et al. Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. JCardiovasc Electrophysiol 2010, 21(9):973-982.
34. Heist E.K., Refaat M., Danik S.B., et al. Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. Heart Rhythm 2006, 3(11):1313-1318.
35. O'Brien J., Al-Hassan D., Ng J., et al. Three-dimensional assessment of left atrial appendage orifice geometry and potential implications for device closure. Int J Cardiovasc Imaging 2014, 30(4):819-823.
36. Chowdhury U.K., Seth S., Govindappa R., et al. Congenital left atrial appendage aneurysm: a case report and brief review of literature. Heart Lung Circ 2009, 18(6):412-416.
37. Bramlet D.A., Edwards J.E. Congenital aneurysm of left atrial appendage. Br Heart J 1981, 45(1):97-100.
38. Collier P., Cavalcante J.L., Phelan D., et al. Congenital absence of the left atrial appendage. Circ Cardiovasc Imaging 2012, 5(4):549-550.
39. Frescura C., Thiene G. Juxtaposition of the atrial appendages. Cardiovasc Pathol 2012, 21(3):169-179.
40. Zhang H., Sun J.P., Zhao Y., et al. Inverted left atrial appendage. Int J Cardiol 2014, 170(3):e57-e58.
41. Davis C.A., Rembert J.C., Greenfield J.C. Compliance of left atrium with and without left atrium appendage. Am J Phys 1990, 259(4 Pt 2):H1006-H1008.
42. Hoit B.D., Walsh R.A. Regional atrial distensibility. Am J Phys 1992, 262(5 Pt 2):H1356-H1360.
43. Hondo T., Okamoto M., Yamane T., et al. The role of the left atrial appendage. A volume loading study in open-chest dogs. Jpn Heart J 1995, 36(2):225-234.
44. Killeen R.P., Ryan R., MacErlane A., et al. Accessory left atrial diverticulae: contractile properties depicted with 64-slice cine-cardiac CT. Int J Cardiovasc Imaging 2010, 26(2):241-248.
45. Goldberg Y.H., Gordon S.C., Spevack D.M., et al. Disparities in emptying velocity within the left atrial appendage. Eur J Echocardiogr 2010, 11(3):290-295.
46. Moe G.W., Grima E.A., Angus C., et al. Response of atrial natriuretic factor to acute and chronic increases of atrial pressures in experimental heart failure in dogs. Role of changes in heart rate, atrial dimension, and cardiac tissue concentration. Circulation 1991, 83(5):1780-1787.
47. Stewart J.M., Dean R., Brown M., et al. Bilateral atrial appendectomy abolishes increased plasma atrial natriuretic peptide release and blunts sodium and water excretion during volume loading in conscious dogs. Circ Res 1992, 70(4):724-732.
48. Stewart J.M., O'Dea D.J., Shapiro G.C., et al. Atrial compliance determines the nature of passive atrial stretch and plasma atrial natriuretic factor in the conscious dog. Cardiovasc Res 1991, 25(9):784-792.
49. Tabata T., Oki T., Yamada H., et al. Relationship between left atrial appendage function and plasma concentration of atrial natriuretic peptide. Eur J Echocardiogr 2000, 1(2):130-137.
50. Winter E.M., van Oorschot A.A., Hogers B., et al. Anew direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells. Circ Heart Fail 2009, 2(6):643-653.
51. Yoshida N., Okamoto M., Nanba K., et al. Transthoracic tissue Doppler assessment of left atrial appendage contraction and relaxation: their changes with aging. Echocardiography 2010, 27(7):839-846.
52. Hoit B.D., Shao Y., Tsai L.M., et al. Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular filling. Circ Res 1993, 72(1):167-175.
53. Kamohara K., Popovic Z.B., Daimon M., et al. Impact of left atrial appendage exclusion on left atrial function. JThorac Cardiovasc Surg 2007, 133(1):174-181.
54. Tabata T., Oki T., Yamada H., et al. Role of left atrial appendage in left atrial reservoir function as evaluated by left atrial appendage clamping during cardiac surgery. Am J Cardiol 1998, 81(3):327-332.
55. Melduni R., Wiggins M., Suri R., et al. Physiological significance of left atrial appendage closure: implication for postoperative atrial fibrillation. JAm Coll Cardiol 2013, 61(10_S).
56. Lee C.H., Kim J.B., Jung S.H., et al. Left atrial appendage resection versus preservation during the surgical ablation of atrial fibrillation. Ann Thorac Surg 2014, 97(1):124-132.
57. Bois J.P., Sheldon S., Stulak J., et al. Surgical therapy for atrial fibrillation: impact of left atrial appendage exclusion or amputation on atrial mechanical function. JAm Coll Cardiol 2014, 63(12_S).
58. Lakkireddy D. Left atrial appendage exclusion as adjunct strategy for AF ablation. Paper presented at: Heart Rhythm Society Annual Sessions. San Francisco, May 9, 2014.
59. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001, 285(22):2864-2870.
60. Rietbrock S., Heeley E., Plumb J., et al. Chronic atrial fibrillation: incidence, prevalence, and prediction of stroke using the congestive heart failure, Hypertension, age>75, diabetes mellitus, and prior stroke or transient ischemic attack (CHADS2) risk stratification scheme. Am Heart J 2008, 156(1):57-64.
61. Lip G.Y., Nieuwlaat R., Pisters R., et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 2010, 137(2):263-272.
62. Lip G.Y., Frison L., Halperin J.L., et al. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 2010, 41(12):2731-2738.
63. Blackshear J.L., Pearce L.A., Hart R.G., et al. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke 1999, 30(4):834-840.
64. Asinger R.W., Koehler J., Pearce L.A., et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: II. Dense spontaneous echocardiographic contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). JAm Soc Echocardiogr 1999, 12(12):1088-1096.
65. Welles C.C., Whooley M.A., Na B., et al. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study. Am Heart J 2011, 162(3):555-561.
66. Wang Y.C., Lin J.L., Hwang J.J., et al. Left atrial dysfunction in patients with atrial fibrillation after successful rhythm control for>3 months. Chest 2005, 128(4):2551-2556.
67. Azarbal F., Welles C.C., Wong J.M., et al. Association of CHADS2, CHA2DS2-VASc, and R2CHADS2 scores with left atrial dysfunction in patients with coronary heart disease (from the Heart and Soul study). Am J Cardiol 2014, 113(7):1166-1172.
68. Puwanant S., Varr B.C., Shrestha K., et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. JAm Coll Cardiol 2009, 54(22):2032-2039.
69. Fukuda S., Watanabe H., Shimada K., et al. Left atrial thrombus and prognosis after anticoagulation therapy in patients with atrial fibrillation. JCardiol 2011, 58(3):266-277.
70. Doukky R., Gage H., Nagarajan V., et al. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography 2013, 30(8):889-895.
71. Doukky R., Garcia-Sayan E., Gage H., et al. The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Cardiovasc Ultrasound 2014, 12(1):10.
72. Di Angelantonio E., Ederhy S., Benyounes N., et al. Comparison of transesophageal echocardiographic identification of embolic risk markers in patients with lone versus non-lone atrial fibrillation. Am J Cardiol 2005, 95(5):592-596.
73. Glotzer T.V., Daoud E.G., Wyse D.G., et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circulation 2009, 2(5):474-480.
74. Healey J.S., Connolly S.J., Gold M.R., et al. Subclinical atrial fibrillation and the risk of stroke. NEngl J Med 2012, 366(2):120-129.
75. Boriani G., Glotzer T.V., Santini M., et al. Device-detected atrial fibrillation and risk for stroke: an analysis of>10,000 patients from the SOS AF project (Stroke prevention strategies based on atrial fibrillation information from implanted devices). Eur Heart J 2014, 35(8):508-516.
76. Boriani G., Botto G.L., Padeletti L., et al. Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 2011, 42(6):1768-1770.
77. Daoud E.G., Glotzer T.V., Wyse D.G., et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. Heart Rhythm 2011, 8(9):1416-1423.
78. Coutinho T., Borlaug B.A., Pellikka P.A., et al. Sex differences in arterial stiffness and ventricular-arterial interactions. JAm Coll Cardiol 2013, 61(1):96-103.
79. Zabalgoitia M., Halperin J.L., Pearce L.A., et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. JAm Coll Cardiol 1998, 31(7):1622-1626.
80. Goldman M.E., Pearce L.A., Hart R.G., et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). JAm Soc Echocardiogr 1999, 12(12):1080-1087.
81. Iwakura K., Okamura A., Koyama Y., et al. Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Am J Cardiol 2011, 107(3):417-422.
82. Pollick C., Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography. Implications for the development of thrombus. Circulation 1991, 84(1):223-231.
83. Fatkin D., Feneley M.P. Patterns of Doppler-measured blood flow velocity in the normal and fibrillating human left atrial appendage. Am Heart J 1996, 132(5):995-1003.
84. Obel O.A., Luddington L., Maarouf N., et al. Effects of ventricular rate and regularity on the velocity and magnitude of left atrial appendage flow in atrial fibrillation. Heart 2005, 91(6):764-768.
85. Kanadasi M., Cayli M., Sahin D.Y., et al. The effect of different atrioventricular delays on left atrium and left atrial appendage function in patients with DDD pacemaker. Echocardiography 2011, 28(6):626-632.
86. Corradi D., Callegari S., Manotti L., et al. Persistent lone atrial fibrillation: clinicopathologic study of 19 cases. Heart Rhythm 2014, 11(7):1250-1258.
87. Akoum N., Fernandez G., Wilson B., et al. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. JCardiovasc Electrophysiol 2013, 24(10):1104-1109.
88. Karabay C.Y., Zehir R., Guler A., et al. Left atrial deformation parameters predict left atrial appendage function and thrombus in patients in sinus rhythm with suspected cardioembolic stroke: a speckle tracking and transesophageal echocardiography study. Echocardiography 2013, 30(5):572-581.
89. Leong D.P., Penhall A., Perry R., et al. Speckle-tracking strain of the left atrium: a transoesophageal echocardiographic validation study. Eur Heart J Cardiovasc Imaging 2013, 14(9):898-905.
90. Sung S.H., Chang S.L., Hsu T.L., et al. Do the left atrial substrate properties correlate with the left atrial mechanical function? A novel insight from the electromechanical study in patients with atrial fibrillation. JCardiovasc Electrophysiol 2008, 19(2):165-171.
91. Watson T., Shantsila E., Lip G.Y. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009, 373(9658):155-166.
92. Jesel L., Arentz T., Herrera-Siklody C., et al. Do atrial differences in endothelial damage, leukocyte and platelet activation, or tissue factor activity contribute to chamber-specific thrombogenic status in patients with atrial fibrillation?. JCardiovasc Electrophysiol 2014, 25(3):266-270.
93. Grimm R.A., Stewart W.J., Maloney J.D., et al. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. JAm Coll Cardiol 1993, 22(5):1359-1366.
94. Di Biase L., Santangeli P., Anselmino M., et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. JAm Coll Cardiol 2012, 60(6):531-538.
95. Anselmino M., Scaglione M., Di Biase L., et al. Left atrial appendage morphology and silent cerebral ischemia in patients with atrial fibrillation. Heart Rhythm 2014, 11(1):2-7.
96. Kimura T., Takatsuki S., Fukuda K. The left atrial appendage: can anatomical characteristics be used to predict strokes in nonvalvular atrial fibrillation patients?. Future Cardiol 2013, 9(4):451-453.
97. Khurram I.M., Dewire J., Mager M., et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm 2013, 10(12):1843-1849.
98. Yamamoto M., Seo Y., Kawamatsu N., et al. Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation. Circ Cardiovasc Imaging 2014, 7(2):337-343.
99. Shirani J., Alaeddini J. Structural remodeling of the left atrial appendage in patients with chronic non-valvular atrial fibrillation: implications for thrombus formation, systemic embolism, and assessment by transesophageal echocardiography. Cardiovasc Pathol 2000, 9(2):95-101.
100. Chatterjee S., Alexander J.C., Pearson P.J., et al. Left atrial appendage occlusion: lessons learned from surgical and transcatheter experiences. Ann Thorac Surg 2011, 92(6):2283-2292.
101. Kanderian A.S., Gillinov A.M., Pettersson G.B., et al. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. JAm Coll Cardiol 2008, 52(11):924-929.
102. Katz E.S., Tsiamtsiouris T., Applebaum R.M., et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study. JAm Coll Cardiol 2000, 36(2):468-471.
103. Healey J.S., Crystal E., Lamy A., et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005, 150(2):288-293.
104. Cullen M.W., Stulak J., Li Z., et al. Value of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation after cardiac surgery. JAm Coll Cardiol 2013, 61(10_S).
105. Klemm H.U., Steven D., Johnsen C., et al. Catheter motion during atrial ablation due to the beating heart and respiration: impact on accuracy and spatial referencing in three-dimensional mapping. Heart Rhythm 2007, 4(5):587-592.
106. Stergiopoulos K., Seifert F., Brown D.L. Thrombus formation after successful stapler exclusion of the left atrial appendage. JAm Coll Cardiol 2010, 55(4):379.
107. Kim R., Baumgartner N., Clements J. Routine left atrial appendage ligation during cardiac surgery may prevent postoperative atrial fibrillation-related cerebrovascular accident. JThorac Cardiovasc Surg 2013, 145(2):582-589. [discussion: 589].
108. Whitlock R.P., Vincent J., Blackall M.H., et al. Left atrial appendage occlusion study II (LAAOS II). Can J Cardiol 2013, 29(11):1443-1447.
109. Whitlock R., Healey J., Vincent J., et al. Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Ann Cardiothorac Surg 2014, 3(1):45-54.
110. Dawson A.G., Asopa S., Dunning J. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?. Interact Cardiovasc Thorac Surg 2010, 10(2):306-311.
111. January C.T., Wann L.S., Alpert J.S., et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 2014, [Epub ahead of print].
112. Nishimura R.A., Otto C.M., Bonow R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129(23):e521-e643.
113. Camm A.J., Lip G.Y., De Caterina R., et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012, 33(21):2719-2747.
114. Yilmaz A., Van Putte B.P., Van Boven W.J. Completely thoracoscopic bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. JThorac Cardiovasc Surg 2008, 136(2):521-522.
115. Muhammad M.I. Role of video-assisted thoracoscopy in the management of stroke. Asian Cardiovasc Thorac Ann 2014, 22(2):155-159.
116. Ohtsuka T., Ninomiya M., Nonaka T., et al. Thoracoscopic stand-alone left atrial appendectomy for thromboembolism prevention in nonvalvular atrial fibrillation. JAm Coll Cardiol 2013, 62(2):103-107.
117. Santini M., Loiaconi V., Tocco M.P., et al. Feasibility and efficacy of minimally invasive stand-alone surgical ablation of atrial fibrillation. A single-center experience. JInterv Card Electrophysiol 2012, 34(1):79-87.
118. Wolf R.K. Treatment of lone atrial fibrillation: minimally invasive pulmonary vein isolation, partial cardiac denervation and excision of the left atrial appendage. Ann Cardiothorac Surg 2014, 3(1):98-104.
119. Zheng S., Li Y., Han J., et al. Long-term results of a minimally invasive surgical pulmonary vein isolation and ganglionic plexi ablation for atrial fibrillation. PLoS One 2013, 8(11):e79755.
120. Kurfirst V., Mokracek A., Bulava A., et al. Two-staged hybrid treatment of persistent atrial fibrillation: short-term single-centre results. Interact Cardiovasc Thorac Surg 2014, 18(4):451-456.
121. Gafoor S., Franke J., Bertog S., et al. Left atrial appendage occlusion in octogenarians: short-term and 1-year follow-up. Catheter Cardiovasc Interv 2014, 83(5):805-810.
122. National Institute for Health and Clinical Excellence: Percutaneous occlusion of the left atrial appendage for atrial fibrillation. 2006. Available at: . Accessed May 12, 2014. http://www.nice.org.uk/nicemedia/pdf/IPG181guidance.pdf.
123. Bartus K., Bednarek J., Myc J., et al. Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm 2011, 8(2):188-193.
124. Bartus K., Han F.T., Bednarek J., et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. JAm Coll Cardiol 2013, 62(2):108-118.
125. Meier B., Palacios I., Windecker S., et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003, 60(3):417-422.
126. Park J.W., Bethencourt A., Sievert H., et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv 2011, 77(5):700-706.
127. Bai R., Horton R.P., DI Biase L., et al. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience. JCardiovasc Electrophysiol 2012, 23(5):455-461.
128. Reddy V.Y., Holmes D., Doshi S.K., et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011, 123(4):417-424.
129. Viles-Gonzalez J.F., Kar S., Douglas P., et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. JAm Coll Cardiol 2012, 59(10):923-929.
130. Reddy VY, Franzen O, Worthley S, etal. Clinical experience with the Wavecrest LA appendage occlusion device for stroke prevention in AF: acute results of the WAVECREST I trial. The Heart Rhythm Society's 35th Annual Scientific Sessions. San Francisco, May 7-10, 2014. p. PO01-112.
131. Sousa J.E., Costa M.A., Tuzcu E.M., et al. New frontiers in interventional cardiology. Circulation 2005, 111(5):671-681.
132. Ostermayer S.H., Reisman M., Kramer P.H., et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. JAm Coll Cardiol 2005, 46(1):9-14.
133. Block P.C., Burstein S., Casale P.N., et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JAm Coll Cardiol 2009, 2(7):594-600.
134. Bayard Y.L., Omran H., Neuzil P., et al. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. Eurointervention 2010, 6(2):220-226.
135. Supreme Court Proceedings of the State of Delaware. Filing ID 54541646. Case Number 515, 2013. 2013.
136. Berti S., Santoro G., Palmieri C., et al. Tools and techniques clinical: transcatheter closure of left atrial appendage using the Amplatzer Cardiac Plug. Eurointervention 2013, 9(4):524-526.
137. Jain A.K., Gallagher S. Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism: NICE guidance. Heart 2011, 97(9):762-765.
138. Cruz-Gonzalez I., Martin Moreiras J., Garcia E. Thrombus formation after left atrial appendage exclusion using an Amplatzer cardiac plug device. Catheter Cardiovasc Interv 2011, 78(6):970-973.
139. Kefer J., Vermeersch P., Budts W., et al. Transcatheter left atrial appendage closure for stroke prevention in atrial fibrillation with Amplatzer cardiac plug: the Belgian Registry. Acta Cardiol 2013, 68(6):551-558.
140. Mohrs O.K., Wunderlich N., Petersen S.E., et al. Contrast-enhanced CMR in patients after percutaneous closure of the left atrial appendage: a pilot study. JCardiovasc Magn Reson 2011, 13:33.
141. Lockwood S.M., Alison J.F., Obeyesekere M.N., et al. Imaging the left atrial appendage prior to, during, and after occlusion. JAm Coll Cardiol 2011, 4(3):303-306.
142. Guerios E.E., Schmid M., Gloekler S., et al. Left atrial appendage closure with the Amplatzer Cardiac Plug in patients with atrial fibrillation. Arq Bras Cardiol 2012, 98(6):528-536.
143. Lopez-Minguez J.R., Eldoayen-Gragera J., Gonzalez-Fernandez R., et al. Immediate and one-year results in 35 consecutive patients after closure of left atrial appendage with the Amplatzer cardiac plug. Rev Esp Cardiol 2013, 66(2):90-97.
144. Lam Y.Y., Yip G.W., Yu C.M., et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv 2012, 79(5):794-800.
145. Versaci F., Sacca S., Mugnolo A., et al. Simultaneous patent foramen ovale and left atrial appendage closure. JCardiovasc Med (Hagerstown) 2012, 13(10):663-664.
146. Viles-Gonzalez J.F., Reddy V.Y., Petru J., et al. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke. JInterv Card Electrophysiol 2012, 33(1):69-75.
147. Freixa X., Chan J.L., Tzikas A., et al. The Amplatzer Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. Eurointervention 2013, 8(9):1094-1098.
148. Freixa X., Kwai Chan J.L., Tzikas A., et al. Percutaneous closure of a very large left atrial appendage using the Amplatzer amulet. Can J Cardiol 2013, 29(10):1329.e9-1329.e11.
149. Holmes D.R., Reddy V.Y., Turi Z.G., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009, 374(9689):534-542.
150. Holmes D.R., Lakkireddy D.R., Whitlock R.P., et al. Left atrial appendage occlusion: opportunities and challenges. JAm Coll Cardiol 2014, 63(4):291-298.
151. Gangireddy S.R., Halperin J.L., Fuster V., et al. Percutaneous left atrial appendage closure for stroke prevention in patients with atrial fibrillation: an assessment of net clinical benefit. Eur Heart J 2012, 33(21):2700-2708.
152. Massarenti L., Yilmaz A. Incomplete endothelialization of left atrial appendage occlusion device 10 months after implantation. JCardiovasc Electrophysiol 2012, 23(12):1384-1385.
153. Reddy V.Y., Mobius-Winkler S., Miller M.A., et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). JAm Coll Cardiol 2013, 61(25):2551-2556.
154. Albers G.W., Diener H.C., Frison L., et al. Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA 2005, 293(6):690-698.
155. Connolly S.J., Ezekowitz M.D., Yusuf S., et al. Dabigatran versus warfarin in patients with atrial fibrillation. NEngl J Med 2009, 361(12):1139-1151.
156. Patel M.R., Mahaffey K.W., Garg J., et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. NEngl J Med 2011, 365(10):883-891.
157. Granger C.B., Alexander J.H., McMurray J.J., et al. Apixaban versus warfarin in patients with atrial fibrillation. NEngl J Med 2011, 365(11):981-992.
158. Amorosi S.L., Armstrong S., Da Deppo L., et al. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation. Europace 2014, 16(8):1131-1136.
159. Whisenant B., Weiss B. Left atrial appendage closure with transcatheter-delivered devices. Intervent Cardiol Clin 2014, 3(2):209-218.
160. Toumanides S., Sideris E.B., Agricola T., et al. Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation. JAm Coll Cardiol 2011, 58(21):2236-2240.
161. Cheng Y., Conditt G., Yi G., et al. TCT-765 first in-vivo evaluation of the Ultrasept left atrial appendage closure device. JAm Coll Cardiol 2012, 60(17_S).
162. Bruce C.J., Stanton C.M., Asirvatham S.J., et al. Percutaneous epicardial left atrial appendage closure: intermediate-term results. JCardiovasc Electrophysiol 2011, 22(1):64-70.
163. Bruce C.J., Asirvatham S.J., McCaw T., et al. Novel percutaneous left atrial appendage closure. Cardiovasc Revasc Med 2013, 14(3):164-167.
164. Santoro F., Di Biase L., Santangeli P., et al. Catheter-based epicardial closure of the left atrial appendage. Intervent Cardiol Clin 2014, 3(2):219-227.
165. Stone D., Byrne T., Pershad A. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation. Catheter Cardiovasc Interv 2013, [Epub ahead of print].
166. Nucifora G., Faletra F.F., Regoli F., et al. Evaluation of the left atrial appendage with real-time 3-dimensional transesophageal echocardiography: implications for catheter-based left atrial appendage closure. Circ Cardiovasc Imaging 2011, 4(5):514-523.
167. Earley M.J. How to perform a transseptal puncture. Heart 2009, 95(1):85-92.
168. Syed F., Lachman N., Christensen K., et al. The pericardial space: obtaining access and an approach to fluoroscopic anatomy. Card Electrophysiol Clin 2010, 2(1):9-23.
169. Baran J., Stec S., Pilichowska-Paszkiet E., et al. Intracardiac echocardiography for detection of thrombus in the left atrial appendage: comparison with transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: the Action-Ice I Study. Circulation 2013, 6(6):1074-1081.
170. Plicht B., Konorza T.F., Kahlert P., et al. Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion. JAm Coll Cardiol 2013, 6(6):606-613.
171. Baker M.S., Paul Mounsey J., Gehi A.K., et al. Left atrial thrombus after appendage ligation with LARIAT. Heart Rhythm 2013, 11(8):1489.
172. Giedrimas E., Lin A.C., Knight B.P. Left atrial thrombus after appendage closure using LARIAT. Circulation 2013, 6(4):e52-e53.
173. Krishnaswamy A., Patel N.S., Ozkan A., et al. Planning left atrial appendage occlusion using cardiac multidetector computed tomography. Int J Cardiol 2012, 158(2):313-317.
174. Chue C.D., de Giovanni J., Steeds R.P. The role ofechocardiography in percutaneous left atrial appendage occlusion. Eur J Echocardiogr 2011, 12(10):i3-i10.
175. MacDonald S.T., Newton J.D., Ormerod O.J. Intracardiac echocardiography off piste? Closure of the left atrial appendage using ICE and local anesthesia. Catheter Cardiovasc Interv 2011, 77(1):124-127.
176. Budge L.P., Shaffer K.M., Moorman J.R., et al. Analysis of invivo left atrial appendage morphology in patients with atrial fibrillation: a direct comparison of transesophageal echocardiography, planar cardiac CT, and segmented three-dimensional cardiac CT. JInterv Card Electrophysiol 2008, 23(2):87-93.
177. Briceno D.F., Fernando R.R., Laing S.T. Left atrial appendage thrombus post LARIAT closure device. Heart Rhythm 2013, 11(1):17-25.
178. Guo X.G., Zhang J.L., Ma J., et al. Management of focal atrial tachycardias originating from the atrial appendage with the combination of radiofrequency catheter ablation and minimally invasive atrial appendectomy. Heart Rhythm 2014, 11(1):17-25.